Hypercontractile esophagus responsive to potassium-competitive acid blockers: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Hypercontractile esophagus responsive to potassium-competitive acid blockers: a case report ; volume:22 ; number:1 ; day:23 ; month:6 ; year:2022 ; pages:1-5 ; date:12.2022
BMC gastroenterology ; 22, Heft 1 (23.6.2022), 1-5, 12.2022
- Urheber
-
Shao, Yuyang
Xie, Chen
Feng, Huang
Yan, Donglin
Chen, Weichang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-022-02375-x
- URN
-
urn:nbn:de:101:1-2022081521181595109628
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shao, Yuyang
- Xie, Chen
- Feng, Huang
- Yan, Donglin
- Chen, Weichang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments
Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers
Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma
Pulmonary vasoconstrictor action of KCNQ potassium channel blockers
Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy
Potassium Channel Blockers Tetraethylammonium and 4-Aminopyridine Fail to Prevent Microglial Activation Induced by Elevated Potassium Concentration
Esophagus
Prediction of effectiveness of potassium-competitive acid blocker and serotonin noradrenaline reuptake inhibitor on abnormal sensation in the throat: use of patient-reported outcome measures (PROMs)
Blocker
Blocker
Blocker
Blocker
Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments
Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers
Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma
Pulmonary vasoconstrictor action of KCNQ potassium channel blockers
Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy
Potassium Channel Blockers Tetraethylammonium and 4-Aminopyridine Fail to Prevent Microglial Activation Induced by Elevated Potassium Concentration
Esophagus
Prediction of effectiveness of potassium-competitive acid blocker and serotonin noradrenaline reuptake inhibitor on abnormal sensation in the throat: use of patient-reported outcome measures (PROMs)
Blocker
Blocker
Blocker
Blocker
Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments
Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers
Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma
Pulmonary vasoconstrictor action of KCNQ potassium channel blockers
Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy
Potassium Channel Blockers Tetraethylammonium and 4-Aminopyridine Fail to Prevent Microglial Activation Induced by Elevated Potassium Concentration
Esophagus
Prediction of effectiveness of potassium-competitive acid blocker and serotonin noradrenaline reuptake inhibitor on abnormal sensation in the throat: use of patient-reported outcome measures (PROMs)
Blocker
Blocker
Blocker